Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997

被引:1
|
作者
Rabilloud, Marie-Laure [1 ]
Bajeux, Emma [2 ]
Siproudhis, Laurent [3 ]
Hamonic, Stephanie [2 ]
Pagenault, Mael [1 ]
Brochard, Charlene [3 ]
Gerfaud, Agathe [4 ]
Dabadie, Alain [4 ]
Viel, Jean-Francois
Tron, Isabelle [5 ]
Robaszkiewicz, Michel [6 ]
Bretagne, Jean-Francois [1 ,2 ]
Bouguen, Guillaume [3 ]
机构
[1] Univ Rennes, CHU Rennes, F-35000 Rennes, France
[2] Univ Hosp Pontchaillou, Dept Publ Hlth, Rennes, France
[3] Univ Rennes, CHU Rennes, INSERM, CIC1414,Inst NUMECAN Nutr Metab & Canc, F-35000 Rennes, France
[4] Hop Sud, Paediat Unit, CHU Rennes, Rennes, France
[5] Observ Reg Sante Bretagne, Rennes, France
[6] Univ Brest, CHU Brest, F-29000 Brest, France
关键词
Crohn's disease; Population-based; Outcomes; INFLAMMATORY-BOWEL-DISEASE; NATURAL-HISTORY; SURGERY; INFLIXIMAB; MANAGEMENT; CLASSIFICATION; BEHAVIOR; THERAPY; RATES; ERA;
D O I
10.1016/j.clinre.2022.101974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The identification of early prognostic factors during Crohn's disease (CD) remains needed for physician decision-making to minimize structural bowel damage, which this study aimed to assess in a population-based setting. Methods: All incident cases of CD were prospectively registered from 1994 to 1997 in Brittany, a limited area of France. All charts of patients were reviewed from the diagnosis to the last clinic visit in 2015. Disabling CD course was defined according to the Saint-Antoine criteria. Results: Among the 331 incident cases of CD, 272 (82%) were followed-up for a median time of 12.8 years. The cumulative probability of developing stricturing or fistulizing CD was 66% at 15 years, and 107 (39%) patients underwent surgery. The cumulative probabilities of immunosuppressant and TNF antagonist use at 15 years were 37% and 22%, respectively. The cumulative risks for disabling disease and bowel damage were 74% and 71% at 15 years, respectively. Systemic symptoms and perianal lesions at diagnosis were independently associated with a disabling disease course. Perianal disease and short disease extension were associated with the onset of bowel damage. Deep ulcers was not predictive of any outcome. Conclusions: A disabling disease course and bowel damage occurred early in the course of CD, which suggests the need for early diagnosis and early treatment, particularly for patients with systematic symptoms and perianal disease. (c) 2022 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU
    Barreiro-de Acosta, Manuel
    Fernandez-Clotet, Agnes
    Mesonero, Francisco
    Garcia-Alonso, Francisco Javier
    Casanova, Maria Jose
    Fernandez-de la Varga, Margarita
    Canete, Fiorella
    de Castro, Luisa
    Gutierrez, Ana
    Sicilia, Beatriz
    Cano, Victoria
    Merino, Olga
    de Francisco, Ruth
    Gonzalez-Partida, Irene
    Suris, Gerard
    Torrealba, Leyanira
    Ferreiro-Iglesias, Rocio
    Castro, Beatriz
    Marquez, Lucia
    Sobrino, Ana
    Elorza, Ainara
    Calvet, Xavier
    Varela, Pilar
    Vicente, Raquel
    Bujanda, Luis
    Lario, Laura
    Mancenido, Noemi
    Garcia-Sepulcre, Mariana F.
    Iglesias, Eva
    Rodriguez, Cristina
    Piqueras, Marta
    Rosique, Juan Angel Ferrer
    Lucendo, Alfredo J.
    Benitez, Olga
    Garcia, Melody
    Olivares, David
    Gonzalez-Munoza, Carlos
    Lopez-Cauce, Beatriz
    Morales Alvarado, Victor Jair
    Spicakova, Katerina
    Brotons, Alicia
    Bermejo, Fernando
    Almela, Pedro
    Ispizua, Nahia
    Gilabert, Pau
    Tardillo, Carlos
    Munoz, Fernando
    Navarro, Pablo
    Dominguez, Rosa Eva Madrigal
    Sendra, Pau
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (06) : 1036 - 1046
  • [42] Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study
    Kassim, Gassan
    Yzet, Clara
    Nair, Nilendra
    Debebe, Anketse
    Rendon, Alexa
    Colombel, Jean-Frederic
    Traboulsi, Cindy
    Rubin, David T.
    Maroli, Annalisa
    Coppola, Elisabetta
    Carvello, Michele M.
    Ben David, Nadat
    De Lucia, Francesca
    Sacchi, Matteo
    Danese, Silvio
    Spinelli, Antonino
    Hirdes, Meike M. C.
    Ten Hove, Joren
    Oldenburg, Bas
    Cholapranee, Aurada
    Riter, Maxine
    Lukin, Dana
    Scherl, Ellen
    Eren, Esen
    Sultan, Keith S.
    Axelrad, Jordan
    Sachar, David B.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (03) : 417 - 422
  • [43] Prevalence and Impact of Obesity in a Population-Based Cohort of Patients With Crohn's Disease
    Johnson, Amanda M.
    Harmsen, William Scott
    Aniwan, Satimai
    Tremaine, William J.
    Raffals, Laura E.
    Abu Dayyeh, Barham K.
    Loftus, Edward V.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (02) : 176 - 182
  • [44] The Spectrum of Perianal Crohn's Disease in a Population-Based Cohort
    Eglinton, Tim W.
    Barclay, Murray L.
    Gearry, Richard B.
    Frizelle, Frank A.
    DISEASES OF THE COLON & RECTUM, 2012, 55 (07) : 773 - 777
  • [45] Long-term outcomes of thalidomide in refractory Crohn's disease
    Gerich, M. E.
    Yoon, J. L.
    Targan, S. R.
    Ippoliti, A. F.
    Vasiliauskas, E. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 429 - 437
  • [46] The Impact of Cholecystectomy on Long-Term Disease Outcomes and Quality of Life in Patients with Crohn's Disease
    Koutroumpakis, Filippos
    Lodhi, Maham
    Ahsan, Maaz
    Rivers, Claudia Ramos
    Schwartz, Marc
    Hashash, Jana G.
    Babichenko, Dmitriy
    Tang, Gong
    Nagpal, Tanvi
    Dunn, Michael
    Keshavarzian, Ali
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (03) : 336 - 343
  • [47] A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study
    Sarter, Helene
    Savoye, Guillaume
    Marot, Guillemette
    Ley, Delphine
    Turck, Dominique
    Hugot, Jean-Pierre
    Vasseur, Francis
    Duhamel, Alain
    Wils, Pauline
    Princen, Fred
    Colombel, Jean-Frederic
    Gower-Rousseau, Corinne
    Fumery, Mathurin
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1793 - 1804
  • [48] Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study
    Sang Hyoung Park
    Sung Wook Hwang
    Min Seob Kwak
    Wan Soo Kim
    Jeong-Mi Lee
    Ho-Su Lee
    Dong-Hoon Yang
    Kyung-Jo Kim
    Byong Duk Ye
    Jeong-Sik Byeon
    Seung-Jae Myung
    Yong Sik Yoon
    Chang Sik Yu
    Jin-Ho Kim
    Suk-Kyun Yang
    Digestive Diseases and Sciences, 2016, 61 : 2060 - 2067
  • [49] Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn's disease treated with antitumor necrosis factor-alpha agents based on Parks' classification
    Azzam, Nahla
    Alharbi, Othman
    Almadi, Majid
    Aljebreen, Abdulrahman
    AlAmeel, Turki
    Alabbas, Mohammed
    Bahammam, Salman
    Bashmail, Ahmed
    Alomar, Yasser
    Mosli, Mahmoud
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (02) : 187 - 192
  • [50] Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies
    Tsai, Lester
    Nguyen, Nghia H.
    Ma, Christopher
    Prokop, Larry J.
    Sandborn, William J.
    Singh, Siddharth
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2451 - 2461